{"title":"迷走神经刺激对耐药性癫痫患者脑电图非周期性成分的长期影响。","authors":"Yujiao Yang, Jing Wang, Xiongfei Wang, Chongyang Tang, Jiahui Deng, Zhaofen Yan, Qinqin Deng, Dong Chen, Jian Zhou, Yuguang Guan, Mengyang Wang, Tianfu Li, Guoming Luan","doi":"10.1177/17562864241279124","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Drug-resistant epilepsy (DRE) affects approximately one-third of epilepsy patients who do not achieve adequate seizure control with medication. Vagus nerve stimulation (VNS) is an adjunctive therapy for DRE, but its long-term effects on cortical excitability remain unclear.</p><p><strong>Objectives: </strong>This study aims to elucidate the long-term effects of VNS on electroencephalography (EEG) aperiodic components in patients with DRE. Our objective is to identify biomarkers that can serve as indicators of therapeutic efficacy and provide mechanistic insights into the underlying neural processes.</p><p><strong>Design: </strong>This longitudinal observational study focused on patients with DRE undergoing VNS therapy at Sanbo Brain Hospital. The reduction in seizure frequency rates was quantified over short-term (⩽1 year), medium-term (1-3 years), and long-term (⩾3 years) intervals to assess the therapeutic efficacy of VNS. Both the periodic and aperiodic components of EEG data were analyzed.</p><p><strong>Methods: </strong>Advanced signal processing techniques were utilized to parameterize the periodic and aperiodic components of EEG data, focusing particularly on \"offset\" and \"exponent.\" These measures were compared before and after VNS therapy. Correlation analyses were conducted to explore the relationship between these EEG parameters and clinical outcomes.</p><p><strong>Results: </strong>In all, 18 patients with DRE participated in this study. During the long-term follow-up period, the responder rate was 55.56%. Significant decreases were observed in aperiodic offset (<i>p</i> = 0.022) and exponent (<i>p</i> = 0.039) among responders. The impact of age on these results was not significant. Correlation analyses revealed a negative association between therapeutic efficacy and a decrease in offset (<i>R</i> = -0.546, <i>p</i> = 0.019) and exponent (<i>R</i> = -0.636, <i>p</i> = 0.019).</p><p><strong>Conclusion: </strong>EEG aperiodic parameters, including offset and exponent, have the potential to serve as promising biomarkers for evaluating the efficacy of VNS. An understanding of the regulatory influence of VNS on cortical excitability through these aperiodic parameters could provide a basis for the development of more effective stimulation parameters and therapeutic strategies.</p>","PeriodicalId":22980,"journal":{"name":"Therapeutic Advances in Neurological Disorders","volume":"17 ","pages":"17562864241279124"},"PeriodicalIF":4.7000,"publicationDate":"2024-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11452897/pdf/","citationCount":"0","resultStr":"{\"title\":\"Long-term effects of vagus nerve stimulation on EEG aperiodic components in patients with drug-resistant epilepsy.\",\"authors\":\"Yujiao Yang, Jing Wang, Xiongfei Wang, Chongyang Tang, Jiahui Deng, Zhaofen Yan, Qinqin Deng, Dong Chen, Jian Zhou, Yuguang Guan, Mengyang Wang, Tianfu Li, Guoming Luan\",\"doi\":\"10.1177/17562864241279124\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Drug-resistant epilepsy (DRE) affects approximately one-third of epilepsy patients who do not achieve adequate seizure control with medication. Vagus nerve stimulation (VNS) is an adjunctive therapy for DRE, but its long-term effects on cortical excitability remain unclear.</p><p><strong>Objectives: </strong>This study aims to elucidate the long-term effects of VNS on electroencephalography (EEG) aperiodic components in patients with DRE. Our objective is to identify biomarkers that can serve as indicators of therapeutic efficacy and provide mechanistic insights into the underlying neural processes.</p><p><strong>Design: </strong>This longitudinal observational study focused on patients with DRE undergoing VNS therapy at Sanbo Brain Hospital. The reduction in seizure frequency rates was quantified over short-term (⩽1 year), medium-term (1-3 years), and long-term (⩾3 years) intervals to assess the therapeutic efficacy of VNS. Both the periodic and aperiodic components of EEG data were analyzed.</p><p><strong>Methods: </strong>Advanced signal processing techniques were utilized to parameterize the periodic and aperiodic components of EEG data, focusing particularly on \\\"offset\\\" and \\\"exponent.\\\" These measures were compared before and after VNS therapy. Correlation analyses were conducted to explore the relationship between these EEG parameters and clinical outcomes.</p><p><strong>Results: </strong>In all, 18 patients with DRE participated in this study. During the long-term follow-up period, the responder rate was 55.56%. Significant decreases were observed in aperiodic offset (<i>p</i> = 0.022) and exponent (<i>p</i> = 0.039) among responders. The impact of age on these results was not significant. Correlation analyses revealed a negative association between therapeutic efficacy and a decrease in offset (<i>R</i> = -0.546, <i>p</i> = 0.019) and exponent (<i>R</i> = -0.636, <i>p</i> = 0.019).</p><p><strong>Conclusion: </strong>EEG aperiodic parameters, including offset and exponent, have the potential to serve as promising biomarkers for evaluating the efficacy of VNS. An understanding of the regulatory influence of VNS on cortical excitability through these aperiodic parameters could provide a basis for the development of more effective stimulation parameters and therapeutic strategies.</p>\",\"PeriodicalId\":22980,\"journal\":{\"name\":\"Therapeutic Advances in Neurological Disorders\",\"volume\":\"17 \",\"pages\":\"17562864241279124\"},\"PeriodicalIF\":4.7000,\"publicationDate\":\"2024-09-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11452897/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Therapeutic Advances in Neurological Disorders\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/17562864241279124\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic Advances in Neurological Disorders","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/17562864241279124","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景:耐药性癫痫(DRE)影响着约三分之一的癫痫患者,他们无法通过药物治疗达到充分的发作控制。迷走神经刺激(VNS)是治疗 DRE 的一种辅助疗法,但其对大脑皮层兴奋性的长期影响仍不清楚:本研究旨在阐明 VNS 对 DRE 患者脑电图(EEG)非周期性成分的长期影响。我们的目标是找出可作为疗效指标的生物标志物,并提供对潜在神经过程的机理认识:这项纵向观察研究主要针对在三博脑科医院接受 VNS 治疗的 DRE 患者。设计:这项纵向观察研究的对象是在三博脑科医院接受 VNS 治疗的 DRE 患者,通过量化短期(⩽1 年)、中期(1-3 年)和长期(⩾3 年)发作频率的减少情况来评估 VNS 的疗效。分析了脑电图数据的周期性和非周期性成分:方法:利用先进的信号处理技术对脑电图数据的周期性和非周期性成分进行参数化处理,尤其侧重于 "偏移 "和 "指数"。这些指标在 VNS 治疗前后进行了比较。进行了相关性分析,以探讨这些脑电图参数与临床结果之间的关系:共有 18 名 DRE 患者参与了这项研究。在长期随访期间,应答率为 55.56%。在应答者中观察到非周期性偏移(p = 0.022)和指数(p = 0.039)显著下降。年龄对这些结果的影响并不显著。相关性分析表明,疗效与偏移量(R = -0.546,p = 0.019)和指数(R = -0.636,p = 0.019)的下降呈负相关:结论:包括偏移量和指数在内的脑电图非周期性参数有望成为评估 VNS 疗效的生物标志物。了解 VNS 通过这些非周期性参数对大脑皮层兴奋性的调节影响,可为开发更有效的刺激参数和治疗策略提供依据。
Long-term effects of vagus nerve stimulation on EEG aperiodic components in patients with drug-resistant epilepsy.
Background: Drug-resistant epilepsy (DRE) affects approximately one-third of epilepsy patients who do not achieve adequate seizure control with medication. Vagus nerve stimulation (VNS) is an adjunctive therapy for DRE, but its long-term effects on cortical excitability remain unclear.
Objectives: This study aims to elucidate the long-term effects of VNS on electroencephalography (EEG) aperiodic components in patients with DRE. Our objective is to identify biomarkers that can serve as indicators of therapeutic efficacy and provide mechanistic insights into the underlying neural processes.
Design: This longitudinal observational study focused on patients with DRE undergoing VNS therapy at Sanbo Brain Hospital. The reduction in seizure frequency rates was quantified over short-term (⩽1 year), medium-term (1-3 years), and long-term (⩾3 years) intervals to assess the therapeutic efficacy of VNS. Both the periodic and aperiodic components of EEG data were analyzed.
Methods: Advanced signal processing techniques were utilized to parameterize the periodic and aperiodic components of EEG data, focusing particularly on "offset" and "exponent." These measures were compared before and after VNS therapy. Correlation analyses were conducted to explore the relationship between these EEG parameters and clinical outcomes.
Results: In all, 18 patients with DRE participated in this study. During the long-term follow-up period, the responder rate was 55.56%. Significant decreases were observed in aperiodic offset (p = 0.022) and exponent (p = 0.039) among responders. The impact of age on these results was not significant. Correlation analyses revealed a negative association between therapeutic efficacy and a decrease in offset (R = -0.546, p = 0.019) and exponent (R = -0.636, p = 0.019).
Conclusion: EEG aperiodic parameters, including offset and exponent, have the potential to serve as promising biomarkers for evaluating the efficacy of VNS. An understanding of the regulatory influence of VNS on cortical excitability through these aperiodic parameters could provide a basis for the development of more effective stimulation parameters and therapeutic strategies.
期刊介绍:
Therapeutic Advances in Neurological Disorders is a peer-reviewed, open access journal delivering the highest quality articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of neurology. The journal has a strong clinical and pharmacological focus and is aimed at clinicians and researchers in neurology, providing a forum in print and online for publishing the highest quality articles in this area.